STERIS plc (STE)

Market Cap	20.95B
Revenue (ttm)	5.33B
Net Income (ttm)	434.80M
Shares Out	98.71M
EPS (ttm)	4.37
PE Ratio	35.67
Forward PE	22.09
Dividend	$2.28 (1.07%)
Ex-Dividend Date	Nov 19, 2024

Volume	755,067
Open	210.08
Previous Close	212.00
Day's Range	208.95 - 213.48
52-Week Range	195.47 - 248.24
Beta	0.85
Analysts	Buy
Price Target	253.00 (+19.2%)
Earnings Date	Nov 6, 2024

About STE

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 1, 1992
• Employees: 18,179
• Stock Exchange: NYSE
• Ticker Symbol: STE
• Website: https://www.steris.com

Financial Performance

In 2023, STERIS's revenue was $5.14 billion, an increase of 13.28% compared to the previous year's $4.54 billion. Earnings were $378.24 million, an increase of 253.40%.

Analyst Forecast

According to 6 analysts, the average rating for STE stock is "Buy." The 12-month stock price forecast is $253.0, which is an increase of 19.20% from the latest price.

Price Target

$253.0

(19.20% upside)

Analyst Consensus: Buy